Insulinomas are neuroendocrine tumors arising from the pancreatic beta cells. Currently,
surgical resection is the therapy of choice, and therefore, preoperative localization of …

Traditional methods for diabetes management require constant and tedious glucose
monitoring (GM) and insulin injections, impacting quality of life. The global diabetic …

Pancreatic beta (β)-cell dysfunction and reduced mass play a central role in the
development and progression of diabetes mellitus. Conventional histological β-cell mass …

Functional nanomaterials have been widely used in biomedical fields due to their good
biocompatibility, excellent physicochemical properties, easy surface modification, and easy …

Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by autoreactive T cells
targeting the insulin-producing beta (β) cells. Despite advances in insulin therapy, T1DM still …

Liraglutide, a human long‐lasting GLP‐1 analogue, is currently regarded as a powerful
treatment option for type 2 diabetes. Apart from glucoregulatory and insulinotropic actions …

Human islet transplantations into rodent models are an essential tool to aid in the
development and testing of islet and cellular-based therapies for diabetes prevention and …

Since diabetes is becoming a global epidemic, there is a great need to develop early β-cell
specific diagnostic techniques for this disorder. There are two types of diabetes (ie, type 1 …

Aberrant expression of miRNAs in pancreatic islets is closely related to the development of
type 1 diabetes (T1D). The aim of this study was to identify key miRNAs dysregulated in …

Type 1 diabetes (T1D) is an incurable condition with an increasing incidence worldwide, in
which the hallmark is the autoimmune destruction of pancreatic insulin-producing β cells …